Advanced search
Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 76, 2021 - Issue 5
Submit an article Journal homepage
209
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Nivolumab and anti-HCV activity, a case report

Laura Wuytsa Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, BelgiumCorrespondence[email protected]
,
Annelies Janssensb Department of Thoracic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium
,
Luisa Vonghiaa Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium;c Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium
,
Peter Michielsena Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium
,
Jo Raskinb Department of Thoracic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium
,
Ann Driessend Department of Pathology, Antwerp University Hospital (UZA), Antwerp, BelgiumORCID Iconhttps://orcid.org/0000-0003-4148-610X
ORCID Icon,
Stijn Van Heesa Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium;c Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, BelgiumORCID Iconhttps://orcid.org/0000-0003-4296-8493
ORCID Icon,
Sven Francquea Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium;c Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium
&
Thomas Vanwolleghema Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium;c Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, BelgiumORCID Iconhttps://orcid.org/0000-0002-0572-8741
ORCID Icon show all
Pages 392-396 | Published online: 17 Mar 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jin Lei, Sibo Yang, Bowen Chen, Linzhi Zhang, Tao Yan, Gangqi Yang, Yue Chen, Yinyin Li, Yinying Lu & Shi Zuo. (2023) Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 357-367.
Read now
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava & Abdelwahab Omri. (2022) Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability. Expert Review of Anti-infective Therapy 20:9, pages 1187-1204.
Read now

Articles from other publishers (1)

K. Rzeniewicz, J. Larkin, A.M. Menzies & S. Turajlic. (2021) Immunotherapy use outside clinical trial populations: never say never?. Annals of Oncology 32:7, pages 866-880.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.